학술논문
A first-in-human study of the anti-LAG-3 antibody favezelimab plus pembrolizumab in previously treated, advanced microsatellite stable colorectal cancer
Document Type
Article
Author
Source
In ESMO Open December 2022 7(6)
Subject
Language
ISSN
2059-7029